⚠ BETA — all market data shown (deals, filings, prices, indices) is demo / illustrative, not live trading data. For evaluation only; verify before acting.
June 17, 2026
Investdesk

NSE

Emmbi Industries LimitedEMMBI

Emmbi Industries Limited is a leading manufacturer of pharmaceuticals, with a focus on developing innovative products for the treatment of various diseases.

Key productsPharmaceuticals, Vaccines
GeographyIndia, Middle East, Africa
CompetitorsSun Pharma, Cipla, Dr. Reddy's Laboratories

AI-generated overview — verify before relying on it.

Net institutional flow

−₹1.4 Cr

Institutional buyers

0 in / 1 out

High-impact filings

0 · tilt Neutral

Next corporate action

Dividend - Re 0.30 Per Share

ex 2025-09-12

Competitive landscape — the read

vs most-traded names · 2Y
1M3M6M1Y2YAll
Institutional money is backing MTNL hardest (+₹41.3 Cr net). EMMBI ranks #4 of 7 on flow (net selling −₹1.4 Cr).
#CompanyInst. flow ₹CrDealsHi-impactFiling mom.BuzzNews
1MTNL+₹41.3 Cr331————
2ATALREAL+₹7 Cr367————
3GATECH+₹0.4 Cr298————
4EMMBIThis−₹1.4 Cr21————
5IRMENERGY−₹2.2 Cr356————
6QUADFUTURE−₹9 Cr581————
7MOBIKWIK−₹150.9 Cr975————

Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.

Timeline — EMMBI day by day

1M3M6M1Y2YAll
  1. 2026-05-14BulkSELL · ₹1.4 CrINTEGRATED INVESTMENT MANAGEMENT SERVICES PRIVATE LIMITED
  2. 2026-05-14NetDay net −₹1.4 Cr
  3. 2025-09-12ActionDividend - Re 0.30 Per ShareDividend
  4. 2025-01-07BulkSELL · ₹1.6 CrHRTI PRIVATE LIMITED
  5. 2025-01-07BulkBUY · ₹2 CrHRTI PRIVATE LIMITED
  6. 2025-01-07NetDay net +₹0.4 Cr
  7. 2024-12-24BulkSELL · ₹1.6 CrHRTI PRIVATE LIMITED
  8. 2024-12-24BulkBUY · ₹1.3 CrHRTI PRIVATE LIMITED
  9. 2024-12-24NetDay net −₹0.4 Cr
  10. 2024-12-23BulkSELL · ₹1.7 CrQE SECURITIES LLP
  11. 2024-12-23BulkBUY · ₹1.7 CrQE SECURITIES LLP
  12. 2024-12-23BulkBUY · ₹2.2 CrNK SECURITIES RESEARCH PRIVATE LIMITED
  13. 2024-12-23BulkSELL · ₹2.2 CrNK SECURITIES RESEARCH PRIVATE LIMITED
  14. 2024-12-23BulkSELL · ₹3.2 CrHRTI PRIVATE LIMITED
  15. 2024-12-23BulkBUY · ₹3.2 CrHRTI PRIVATE LIMITED
  16. 2024-12-23BulkBUY · ₹1.7 CrAAKRAYA RESEARCH LLP
  17. 2024-12-23BulkSELL · ₹1.7 CrAAKRAYA RESEARCH LLP
  18. 2024-12-23NetDay net −₹0 Cr
  19. 2024-12-20BulkSELL · ₹2.2 CrHRTI PRIVATE LIMITED
  20. 2024-12-20BulkBUY · ₹2 CrHRTI PRIVATE LIMITED
  21. 2024-12-20NetDay net −₹0.2 Cr
  22. 2024-12-16BulkSELL · ₹1.4 CrAKHIL KAKKAR
  23. 2024-12-16BulkBUY · ₹2 CrAKHIL KAKKAR
  24. 2024-12-16NetDay net +₹0.6 Cr
  25. 2024-09-13ActionDividend - Re 0.30 Per ShareDividend
  26. 2024-09-11BulkSELL · ₹1.5 CrNK SECURITIES RESEARCH PRIVATE LIMITED
  27. 2024-09-11BulkBUY · ₹1.5 CrNK SECURITIES RESEARCH PRIVATE LIMITED
  28. 2024-09-11BulkBUY · ₹1.7 CrHRTI PRIVATE LIMITED
  29. 2024-09-11BulkSELL · ₹1.4 CrHRTI PRIVATE LIMITED
  30. 2024-09-11NetDay net +₹0.3 Cr

Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.

Filings that matter

No scored filings for EMMBI yet.

Institutional flow (weekly net)

05-11
−₹1Cr

Bulk & block deals

1M3M6M1Y2YAll

21 deals · 2024-09-11 → 2026-05-14

DateCounterpartyTypeSideValue
2026-05-14INTEGRATED INVESTMENT MANAGEMENT SERVICES PRIVATE LIMITEDInstitutionSELL₹1.4 Cr
2025-01-07HRTI PRIVATE LIMITEDProp / churnSELL₹1.6 Cr
2025-01-07HRTI PRIVATE LIMITEDProp / churnBUY₹2 Cr
2024-12-24HRTI PRIVATE LIMITEDProp / churnSELL₹1.6 Cr
2024-12-24HRTI PRIVATE LIMITEDProp / churnBUY₹1.3 Cr
2024-12-23QE SECURITIES LLPProp / churnSELL₹1.7 Cr
2024-12-23QE SECURITIES LLPProp / churnBUY₹1.7 Cr
2024-12-23NK SECURITIES RESEARCH PRIVATE LIMITEDProp / churnBUY₹2.2 Cr
2024-12-23NK SECURITIES RESEARCH PRIVATE LIMITEDProp / churnSELL₹2.2 Cr
2024-12-23HRTI PRIVATE LIMITEDProp / churnSELL₹3.2 Cr

21 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.

News & chatter on EMMBI

RSS News

0

No recent news.

Google News RSS — links open the source.

Investdesk

0

No articles yet.

Our coverage.

Reddit

0

No Reddit chatter.

r/ posts mentioning the company.

Twitter / X

0

No posts.

Posts mentioning the company.